Please login to the form below

Not currently logged in
Email:
Password:

Bain Capital

This page shows the latest Bain Capital news and features for those working in and with pharma, biotech and healthcare.

Coronavirus disruption scuppers Curium Pharma sale

Coronavirus disruption scuppers Curium Pharma sale

Three potential buyers for Curium – said to include investment groups Nordic Capital, Bain Capital and CVC Capital Partners – are said to have lowered their bids for France-based Curium amid turmoil

Latest news

  • Editas CEO exits the CRISPR firm ahead of first clinical trial Editas CEO exits the CRISPR firm ahead of first clinical trial

    managing director at investment group Bain Capital, and a few months after chief medical officer Gerald Cox also stepped down.

  • Pfizer spins out SpringWorks Therapeutics biotech Pfizer spins out SpringWorks Therapeutics biotech

    funding from the drugmaker plus venture capitalists Bain Capital and Orbimed and medical charity LifeArc. ... Pfizer is contributing both equity capital and royalty- and milestone-bearing licenses to the experimental therapies.

  • No deal for Stada as private equity takeover bid collapses No deal for Stada as private equity takeover bid collapses

    Bain Capital and Cinven's planned buyout of Germany's Stada has failed at the last hurdle, with too few of Stada's shareholders agreeing to the deal by the deadline. ... Stada's board had lent its support to the Bain-Cinven offer over a rival 58 per

  • Private equity firms agree deal to take over Stada Private equity firms agree deal to take over Stada

    Cinven and Bain Capital beat out competition from Advent International. The board of German pharma company Stada has agreed to a takeover deal with two of three interested private equity companies, ... Cinven and Bain Capital made what Stada said was the

  • Stada opens books to let formal bidding commence Stada opens books to let formal bidding commence

    Cinven, Advent International and Bain Capital now have opportunity to revise their bids. ... The three interested parties - confirmed as Cinven, Advent International and Bain Capital - will now all receive the "same level of information" and so have the

More from news
Approximately 2 fully matching, plus 9 partially matching documents found.

Latest Intelligence

  • The changing nature of approvals – what does the future hold? The changing nature of approvals – what does the future hold?

    High-profile disinvestments include those by Pfizer and Eli Lilly. However, Pfizer has since announced that, together with investment firm Bain Capital, it has created a new drug company called Cerevel

  • Deal Watch - May 2017 Deal Watch - May 2017

    Intas (pharma). 106. Bain and others. Investment. Dicerna (biotech). 70. M&A without debt. ... 4, 750 (incl. debt). Stada (DE). Bain Capital and Cinven. Company acquisition.

  • Deal Watch February 2017 Deal Watch February 2017

    A third suitor is believed to be another PE firm, Bain Capital.

  • Deal Watch February 2016 Deal Watch February 2016

    A couple of weeks later Stryker paid $1.28bn (approximately 2.5 x sales) to buy Physio-Control from Bain Capital. ... Founded in the 1950s, Physio-Control is a pioneer of defibrillator/monitor technologies and was owned by Lilly and then Medtronic before

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Madmicrobe Studios

MadMicrobe is an award-winning team of certified medical illustrators creating animations that draw audiences into a world of suspense, excitement,...

Latest intelligence

WHITE PAPER: Why do men die younger?
It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials
Here are some useful tips to help get your hands on authentically diverse stock photos....
01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...

Infographics